[1] | Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2): 1-2. | [2] | Siles-Lucas M, Casulli A, Cirilli R, et al. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets[J]. PLoS Negl Trop Dis, 2018, 12(4): e0006422. | [3] | Stojkovic M, Mickan C, Weber TF, et al. Pitfalls in diagnosis and treatment of alveolar echinococcosis: a sentinel case series[J]. BMJ Open Gastroenterol, 2015, 2(1): e000036. | [4] | Spiliotis M, Lechner S, Tappe D, et al. Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles[J]. Int J Parasitol, 2008, 38(8/9): 1025-1039. | [5] | Spiliotis M, Brehm K. Axenic in vitro cultivation of Echinococcus multilocularis metacestode vesicles and the generation of primary cell cultures[J]. Methods Mol Biol, 2009, 470(1): 245-262. | [6] | Flory J, Lipska K. Metformin in 2019[J]. JAMA, 2019, 321(19): 1926-1927. | [7] | Harati R, Vandamme M, Blanchet B, et al. Drug-drug interaction between metformin and sorafenib alters antitumor effect in hepatocellular carcinoma cells[J]. Mol Pharmacol, 2021, 100(1): 32-45. | [8] | Ashrafizadeh M, Mirzaei S, Hushmandi K, et al. Therapeutic potential of AMPK signaling targeting in lung cancer: advances, challenges and future prospects[J]. Life Sci, 2021, 278: 119649. | [9] | Koroglu-Aydn P, Bayrak BB, Bugan I, et al. Histological and biochemical investigation of the renoprotective effects of metformin in diabetic and prostate cancer model[J]. Toxicol Mech Methods, 2021, 31(7): 489-500. | [10] | Alhourani AH, Tidwell TR, Bokil AA, et al. Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells[J]. Sci Rep, 2021, 11(1): 1-10. | [11] | Wang Z, Guo JJ, Han XQ, et al. Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE(-/-) mice[J]. Cell Biosci, 2019, 9(1): 1-15. | [12] | Guo LM, Cui J, Wang HR, et al. Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways[J]. Mol Ther Oncolytics, 2021, 20: 119-131. | [13] | Ouyang JY, Parakhia RA, Ochs RS. Metformin activates AMP kinase through inhibition of AMP deaminase[J]. J Biol Chem, 2011, 286(1): 1-11. | [14] | Zheng LY, Yang W, Wu FQ, et al. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma[J]. Clin Cancer Res, 2013, 19(19): 5372-5380. | [15] | Loos JA, Dávila VA, Brehm K, et al. Metformin suppresses development of the Echinococcus multilocularis larval stage by targeting the TOR pathway[J]. Antimicrob Agents Chemother, 2020, 64(9): e01808-e01827. | [16] | Brehm K, Wolf M, Beland H, et al. Analysis of differential gene expression in Echinococcus multilocularis larval stages by means of spliced leader differential display[J]. Int J Parasitol, 2003, 33(11): 1145-1159. | [17] | Hemer S, Brehm K. In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae[J]. Int J Antimicrob Agents, 2012, 40(5): 458-462. | [18] | Stadelmann B, Aeschbacher D, Huber C, et al. Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes[J]. PLoS Negl Trop Dis, 2014, 8(12): e3352. | [19] | Cheng Z, Xu Z, Tian H, et al. In vitro and efficacies of inhibitors of the EGFR/MEK/ERK signaling in the treatment of alveolar echinococcosis[J]. Antimicro Agents Chemo, 2020, 64(8): 234-236. | [20] | Saraei P, Asadi I, Kakar MA, et al. The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances[J]. Cancer Manag Res, 2019, 11: 3295-3313. | [21] | Sanli T, Steinberg GR, Singh G, et al. AMP-activated protein kinase (AMPK) beyond metabolism[J]. Cancer Biol Ther, 2014, 15(2): 156-169. | [22] | Jia JY, Bissa B, Brecht L, et al. AMPK, a regulator of metabolism and autophagy, is activated by lysosomal damage via a novel galectin-directed ubiquitin signal transduction system[J]. Mol Cell, 2020, 77(5): 951-969. | [23] | Zaidi S, Gandhi J, Joshi G, et al. The anticancer potential of metformin on prostate cancer[J]. Prostate Cancer Prostatic Dis, 2019, 22(3): 351-361. | [24] | Fan H, Yu X, Zou Z, et al. Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway[J]. Carcinogenesis, 2019, 40(5): 669-679. | [25] | Lee J, Hong EM, Kim JH, et al. Metformin induces apoptosis and inhibits proliferation through the AMP-activated protein kinase and insulin-like growth factor 1 receptor pathways in the bile duct cancer cells[J]. J Cancer, 2019, 10(7): 1734-1744. | [26] | Guillermo M, Mireia NS, Eric HB, et al. Self-consumption: the interplay of autophagy and apoptosis[J]. Nat Rev Mol Cell Biol, 2014, 15(2): 81-90. | [27] | Wang Y, Zhang YF, Feng XM, et al. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells[J]. Oncol Rep, 2021, 45(3): 1249-1260. | [28] | Yang HC, Zhang HW, Shi KJ, et al. Autocrine osteopontin promotes the growth and metastasis of Echinococcus multilocu-laris via the EGFR signaling pathway[J]. Chin J Parasitol Parasit Dis, 2021, 39(2): 226-232. (in Chinese) | [28] | (杨海成, 张宏伟, 史康杰, 等. 自分泌骨桥蛋白通过EGFR信号通路促进多房棘球蚴生长和转移的研究[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2): 226-232.) | [29] | Tan XW, Yu XF, Jiang HQ, et al. Inhibitory effect of xanthohumol on the growth of Echinococcus multilocularis[J]. Chin J Parasitol Parasit Dis, 2021, 39(3): 304-310. (in Chinese) | [29] | (谭小武, 俞晓凡, 姜慧娇, 等. 黄腐酚对小鼠肝多房棘球蚴生长的抑制作用[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(3): 304-310.) |
|